DLB · Dolby Laboratories, Inc.
Market Cap
$5.76B
Shares
93.67M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$61.56
Open$61.33
Day$60.14–62.30
52W close$48.51–73.29
Avg vol 30d968K
Short int5.9M · 6.3% float · 6.5d
Short vol52%
Last earningsJul 30, 2026
DataJan 2020–Aug 2026
Filing10-Q · Jul 30
Up next
Next earnings call
Oct 29, 2026
Est · unconfirmed
· in 8 wks
FQ4-26 quarter ends
~Sep 27, 2026
Est
filed Jul 30, 2026
AI Brief
Q2 FY26 earnings call · Apr 30, 2026
Q2 FY26
TL;DR. Dolby reported Q2 FY2026 revenue of $396M and non-GAAP EPS of $1.37, both within prior guidance, with full-year guidance maintained. The quarter was highlighted by expanded Dolby Atmos/Vision adoption across automotive, mobile, sports content and TV, with new wins at BMW, Lexus, Meta and Douyin.
Bullish
- + Q2 revenue grew to $396M from $370M a year ago, with non-GAAP EPS rising to $1.37 from $1.34. new
- + BMW launched Dolby Atmos in the 7 Series globally and iX3 in China; Lexus announced first Dolby Atmos-enabled cars; BYD launched Dolby Atmos in Europe via Denza line. new
- + Meta adopted Dolby Vision on iOS for Instagram and Facebook, and Douyin fully rolled out Dolby Vision on Android. new
- + Hisense, TCL and Philips announced plans to release Dolby Vision 2 TVs globally by fiscal year-end, with Peacock and Canal+ committed to content. new
- + Video Distribution Program added Sharp and SK Planet as licensors, bringing total to 40; Dolby OptiView wins included Genius Sports and William Hill. new
- + Quarterly dividend raised 9% to $0.36; $93M in operating cash flow generated and $65M of stock repurchased. new
Bearish
- − Mobile licensing revenue declined 6% year-over-year due to timing of deals.
- − Broadcast end market growth of 26% was driven by a large recovery noted on the prior call, implying potential normalization later. new
- − Q2 included a $2M restructuring charge in GAAP operating expenses related to actions initiated last year. new
- − Memory pricing and broader macro factors are being monitored, with mobile and PC viewed as most exposed; no significant impact seen to date but uncertainty remains. new
- − GAAP net income was $95M ($0.99/diluted share), only modestly above the prior-year quarter despite revenue growth. new
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Neutral
Momentum
Weak
Sentiment
Neutral
Fundamentals
Strong
Quant / Vol
Moderate
Market backdrop
VIX 14.9 · calm
Equity put/call 0.70
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+2%
above
Price vs 50-day avg
+10%
above
RSI (14)
54
neutral
MACD trend
Negative
52-week position
53%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+3%
trailing
6-month return
−4%
trailing
YTD return
−4%
this year
Relative strength
−17%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $56 › 200d $60 — 200d above 50d
Institutional flow
Distributing
-7% holders QoQ · +52 funds added
Insider flow
Distributing
Net -$182.5K over 90 days · 100% sells
Short interest
Falling
6.29% of float · ▼ -6.5% MoM · 6.5 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
391 holders — near 3-yr low, contrarian setup
Squeeze score
72
high risk · 0–100
Fundamentals
Revenue growth
+10%
Y/Y
Gross margin
93%
contracting
EPS growth
−3%
Y/Y
Free cash flow
$435.9M
Valuation
P/E 26.3
in line
Buyback
$427.0M
remaining
Quant / Vol
risk profile
Volatility
29%
annualized · 1-yr
Max drawdown
−34%
past year
ATR
2.9%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the 8-K filed Jul 30, 2026
fourth quarter of fiscal 2026
Total revenue
Initiated
$362M – $392M
prior qtr $305M
midpoint +23.6% QoQ
Licensing revenue
Initiated
$335M – $365M
Gross margins
Initiated
90%
Gross margins
Initiated
88%
Operating expenses
Initiated
$195M – $205M
Operating expenses
Initiated
$227M – $237M
Effective tax rate
Initiated
23%
Diluted earnings per share
Initiated
$0.78 – $0.93
prior qtr $0.30
midpoint +185.0% QoQ
Effective tax rate
Initiated
21%
Diluted earnings per share
Initiated
$1.13 – $1.28
full year of fiscal 2026
Total revenue
Maintained
$1.41B – $1.44B
Apr 30, 2026
$1.4B – $1.45B
changed to
Jul 30, 2026
$1.41B – $1.44B
prior FY $1.35B
midpoint +5.6% Y/Y
Licensing revenue
Raised
$1.31B – $1.34B
Apr 30, 2026
$1.3B – $1.35B
changed to
Jul 30, 2026
$1.31B – $1.34B
Gross margins
Maintained
90%
Apr 30, 2026
90%
changed to
Jul 30, 2026
90%
Gross margins
Maintained
88%
Apr 30, 2026
88%
changed to
Jul 30, 2026
88%
Operating expenses
Raised
$937M – $947M
Apr 30, 2026
$930M – $950M
changed to
Jul 30, 2026
$937M – $947M
Operating expenses
Maintained
$785M – $795M
Apr 30, 2026
$780M – $800M
changed to
Jul 30, 2026
$785M – $795M
Effective tax rate
Raised
24%
Apr 30, 2026
23%
changed to
Jul 30, 2026
24%
Diluted earnings per share
Lowered
$2.62 – $2.77
Apr 30, 2026
$2.66 – $2.81
changed to
Jul 30, 2026
$2.62 – $2.77
prior FY $2.62
midpoint +2.9% Y/Y
Effective tax rate
Raised
21%
Apr 30, 2026
20%
changed to
Jul 30, 2026
21%
Diluted earnings per share
Lowered
$4.25 – $4.40
Apr 30, 2026
$4.30 – $4.45
changed to
Jul 30, 2026
$4.25 – $4.40
Prior guidance
period ended
· from the 8-K filed Apr 30, 2026
Total revenue
· third quarter of fiscal 2026
$295M – $325M
Gross margins
· third quarter of fiscal 2026
86%
Licensing revenue
· third quarter of fiscal 2026
$270M – $300M
Operating expenses
· third quarter of fiscal 2026
$235M – $245M
Gross margins
· third quarter of fiscal 2026
88%
Effective tax rate
· third quarter of fiscal 2026
21%
Operating expenses
· third quarter of fiscal 2026
$200M – $210M
Diluted earnings per share
· third quarter of fiscal 2026
$0.19 – $0.34
Effective tax rate
· third quarter of fiscal 2026
23%
Diluted earnings per share
· third quarter of fiscal 2026
$0.56 – $0.71
Guided vs delivered
· last 8 settled
Total revenue
third quarter of fiscal 2026
guided $295M – $325M
$305M
In line
Diluted earnings per share
third quarter of fiscal 2026
guided $0.19 – $0.34
$0.30
In line
Total revenue
first quarter of fiscal 2026
guided $315M – $345M
$346.71M
Beat +5.1%
Diluted earnings per share
first quarter of fiscal 2026
guided $0.39 – $0.54
$0.55
Beat +18.3%
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+2%
Bullish
Price vs 50-day avg
+10%
Bullish
RSI (14)
54
Neutral
MACD trend
Negative
Bearish
52-week position
53%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross)
No cross
50d $56 › 200d $60 — 200d above 50d
Institutional flow
Distributing
-7% holders QoQ · +52 funds added
Insider flow
Distributing
Net -$182.5K over 90 days · 100% sells
Short interest
Falling
6.29% of float · ▼ -6.5% MoM · 6.5 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
391 holders — near 3-yr low, contrarian setup
Price context
position in its 52-week range
Range low $49
Now $62 · 53%
Range high $73
vs 200-day avg +2%
vs 50-day avg +10%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| stock repurchase authorization available | 142M | second quarter of fiscal 2026 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Specialty Business Services — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
DLB
this stock
Dolby Laboratories, Inc.
|
$5.76B | -4.1% | +10.3% | 26.3 | 6.3% |
|
CTAS
Cintas Corp
|
$81.71B | +7.3% | +6.4% | 41.6 | 2.6% |
|
RELX
Relx PLC
|
$63.64B | -9.6% | — | — | 0.3% |
|
TRI
Thomson Reuters Corp /Can/
|
$46.02B | -19.5% | — | — | 2.9% |
|
CPRT
Copart Inc
|
$30.54B | -15.7% | +24.7% | 20.6 | 4.9% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| DLB | -6.8% | +3.1% | -3.8% | +4.7% | -4.1% |
| SPY | +0.5% | +3.0% | +13.4% | +3.0% | +12.8% |
| vs SPY | -7.3% | +0.1% | -17.2% | +1.7% | -17.0% |
Capital returns
Latest dividend
$0.36
/ share · ex Aug 11, 2026
Paid (TTM)
$1.44
/ share · 4 payouts
Dividend yield (TTM, derived)
2.34%
Buyback programs
· 2 active
· as of Jul 30, 2026
Authorized (total)
$777.00M
Spent (derived)
$350.00M
Remaining
$427.00M
Spent
Remaining
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.
Key facts
CIK
1308547
CUSIP
25659T107
13F (30d)
292 filings
282 filers
Visit website
Investor relations